Physician profile

Joseph Koscielniak

Merrillville, IN

NPI 1841299468

$2,670.76

in general payments reported to CMS, 2019-2025

7 companies · $132 in 2025

The $132 reported for 2025 was less than what a typical provider received nationally.

Payments by year

General payments by program year, as reported to CMS.

What the payments were for

Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.

View as a table
Payment typeAmount (2023-2025)
Food and Beverage$150.08
Travel and Lodging$12.94

Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.

Who reported paying

General payments only, as reported to CMS. Product names cover 2023-2025.

CompanyGeneral paymentsYearsTop products
Medwest Associates $2,411.51 2022
Lightbody Medical Technologies INC $131.79 2025
Endo Pharmaceuticals INC. $41.64 2020-2021
Heron Therapeutics, INC. $30.00 2022
Stryker Corporation $24.59 2021
Treace Medical Concepts, INC. $18.29 2023
Acumed LLC $12.94 2023 Osteomed

Drugs and devices associated with these payments

CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.

If you want to bring it up

Most clinicians are glad to talk about this. A respectful way in:

These are normal questions. A good clinician will welcome them.

Share this page

Payment summary

Joseph Koscielniak

$2,670.76

in general payments reported 2019-2025

Years
2020-2025
Top company
Medwest Associates
Context
The $132 reported for 2025 was less than what a typical provider received nationally.

https://glasscript.com/doctor/38704/joseph-koscielniak

Source: CMS Open Payments, program years 2019-2025. Payments are legal and often routine.

Keep an eye on this page

Get an email when the next June refresh changes this page. No account needed.

Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.